REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

27 Mar 2015 07:11

RNS Number : 6618I
J.P. Morgan Securities PLC.
27 March 2015
 



NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

RESULT OF PLACING OF ORDINARY SHARES IN ABCAM PLC

 

Further to the announcement made on 26 March 2015, Dr. Jonathan Milner, a Director of Abcam PLC ("Abcam" or the "Company") and certain Trusts, of which Dr Jonathan Milner is a trustee, announce that they have sold in aggregate 4,630,000 ordinary shares of 0.2 pence each in the Company (the "Placing Shares") at a price of 465 pence per Placing Share (the "Placing") raising in aggregate gross proceeds of approximately £21.5 million.

 

The proceeds of the Placing are payable in cash on usual settlement terms, and closing of the Placing is expected to occur on a T+2 basis on 31 March 2015, subject to the satisfaction or waiver of certain customary conditions.

 

Following this transaction, Dr Milner's total interest in the Company has decreased by 4,630,000 ordinary shares and is now 23,303,266 ordinary shares of 0.2p each, representing approximately 11.6% of the Company's issued share capital.

 

J.P. Morgan Securities plc (which conducts its investment banking activities as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove") and Peel Hunt LLP ("Peel Hunt") are acting as Joint Bookrunners in connection with the Placing.

 

 

Enquiries:

 

J.P.Morgan Cazenove + 44 (0) 20 7742 4000

James Mitford / Charles Pretzlik

 

Peel Hunt + 44 (0) 20 7418 8900

Clare Terlouw / Al Rae

 

 

IMPORTANT NOTICE

 

MEMBERS OF THE GENERAL PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES ARE ONLY ADDRESSED TO AND DIRECTED AT (1) PERSONS IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(1)(E) OF EU DIRECTIVE 2003/71/EC, AS AMENDED, INLCUDING BY THE 2010 PROSPECTUS DIRECTIVE AMENDING DIRECTIVE 2010/73/EC TO THE EXTENT IMPLEMENTED IN THE RELEVANT MEMBER STATE (THE "PROSPECTUS DIRECTIVE") ("QUALIFIED INVESTORS"); and (2) PERSONS IN THE UNITED KINGDOM, PERSONS WHO ARE QUALIFIED INVESTORS AND WHO (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) (THE "ORDER"); OR (II) FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER OR (III) ARE PERSONS TO WHOM THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES MAY OTHERWISE BE LAWFULLY COMMUNICATED OR MADE (ALL SUCH PERSONS REFERRED TO IN (1) AND (2) TOGETHER BEING REFERRED TO AS "RELEVANT PERSONS"). THE INFORMATION REGARDING THE PLACING SET OUT IN THIS ANNOUNCEMENT MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

 

This announcement and the information contained herein is for information purposes only and does not constitute or form part of any offer or an invitation to acquire or dispose of securities in the United States, Australia, Canada, Japan, the Republic of South Africa or in any other jurisdiction in which such an offer or solicitation is unlawful.

 

The Placing Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and, absent registration, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and the securities laws of any relevant state or other jurisdiction of the United States. There will be no public offering of the Placing Shares in the United States or elsewhere.

 

The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.

 

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by any of the Sellers, J.P. Morgan Cazenove or Peel Hunt or any of their respective affiliates.

 

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in or into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Japan or the Republic of South Africa. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws.

 

The distribution of this announcement and the offering or sale of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Sellers, J.P. Morgan Cazenove or Peel Hunt or any of their respective affiliates that would, or which is intended to, permit a public offer of the Placing Shares in any jurisdiction or possession or distribution of this announcement or any other offering or publicity material relating to the Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Sellers, J.P. Morgan Cazenove or Peel Hunt to inform themselves about and to observe any applicable restrictions.

 

J.P. Morgan Securities plc, which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting only for the Sellers in connection with the Placing and will not be responsible to anyone other than the Sellers for providing the protections offered to the clients of J.P. Morgan Securities plc, nor for providing advice in relation to the Placing or any matters referred to in this announcement.

 

Peel Hunt LLP, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting only for the Sellers in connection with the Placing and will not be responsible to anyone other than the Sellers for providing the protections offered to the clients of Peel Hunt LLP, nor for providing advice in relation to the Placing or any matters referred to in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZFNNNGKZG
Date   Source Headline
14th Dec 20227:00 amRNSCancellation - Abcam Plc
12th Dec 20228:00 amRNSUpdate on AIM Delisting
9th Dec 20225:30 pmRNSAbcam
8th Dec 20222:36 pmRNSHolding(s) in Company
30th Nov 20228:55 amRNSTotal Voting Rights
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
17th Nov 20223:59 pmRNSDirector/PDMR Shareholding
17th Nov 20223:57 pmRNSDirector/PDMR Shareholding
11th Nov 20223:30 pmRNSResult of General Meeting
31st Oct 20223:22 pmRNSTotal Voting Rights
17th Oct 20227:00 amRNSPropose cancellation of AIM shares notice of GM
17th Oct 20227:00 amRNSProposed cancellation of AIM shares & notice of GM
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20222:01 pmRNSDirector/PDMR Shareholding
10th Oct 20221:59 pmRNSDirector/PDMR Shareholding
30th Sep 20223:50 pmRNSBlock Listing Six Monthly Return
30th Sep 20223:48 pmRNSTotal Voting Rights
12th Sep 202212:00 pmRNSInterim results for the period ended 30 June 2022
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
1st Sep 20222:02 pmRNSAbcam attend Morgan Stanley Healthcare Conference
31st Aug 202211:16 amRNSTotal Voting Rights
17th Aug 20228:30 amRNSNotice of Results
29th Jul 202211:09 amRNSTotal Voting Rights
20th Jul 202212:00 pmRNSTrading Statement
4th Jul 20228:36 amRNSTotal Voting Rights
31st May 20224:22 pmRNSTotal Voting Rights
18th May 20224:30 pmRNSResult of AGM
3rd May 202212:41 pmRNSDirector/PDMR Shareholding
29th Apr 20224:01 pmRNSTotal Voting Rights
5th Apr 20224:35 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSPublication of 2021 ARA and Notice of AGM
31st Mar 202210:58 amRNSTotal Voting Rights
30th Mar 20222:41 pmRNSBlock listing Interim Review
28th Mar 20223:09 pmRNSBlock Listing application of Ordinary Shares
17th Mar 20221:18 pmRNSDirector/PDMR Shareholding Notification
14th Mar 202212:00 pmRNSResults for the period ended 31 December 2021
2nd Mar 20227:00 amRNSTotal Voting Rights
28th Feb 20227:00 amRNSNotice of Full Year Results
4th Feb 202212:02 pmRNSDirector/PDMR Shareholding
31st Jan 202211:49 amRNSTotal Voting Rights
27th Jan 202212:00 pmRNSTrading Statement
31st Dec 202112:49 pmRNSTotal Voting Rights
2nd Dec 20217:00 amRNSUpdate on 2021 General Meeting Resolution Vote
30th Nov 20213:25 pmRNSTotal Voting Rights
12th Nov 20215:28 pmRNSIssue of Equity and Replacement PDMR Notification
12th Nov 20214:17 pmRNSTotal Voting Rights
12th Nov 202112:34 pmRNSIssue of Equity and Replacement PDMR Notification
10th Nov 20214:56 pmRNSIssue of Equity and PDMR Notification
5th Nov 20213:19 pmRNSVesting of All Employee Share Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.